Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the complete record of transactions filed by Mollenkopf, Dr. Claudine, Management Board. Director active across 1 company, notably Evonik Industries AG. Cumulatively, 1 disclosures have been logged. Activity tracked since 2 June 2025. The latest transaction was disclosed on 2 June 2025 (Buy). Regulator: BaFin. The full history is free.
1 of 1 declaration
Dr. Claudine Mollenkopf is a member of the Management Board at Evonik Industries AG. In this role, she is responsible for overseeing the company's operations and strategy. Her expertise in the chemical sector enables her to contribute to Evonik's strategic direction. Claudine is committed to improving operational efficiency and strengthening the company's market position.